Jianyong Ma
-
- Atrial Fibrillation Management and Outcomes 27
- Cardiovascular Function and Risk Factors 14
- Cardiac Arrhythmias and Treatments 8
- Heart Failure Treatment and Management 6
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 9
- Nephrology top 10%
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 9
-
- Effects and risks of endocrine disrupting chemicals 7
-
- Liver Disease Diagnosis and Treatment 6
Jianyong Ma
84 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Cardiology and Cardiovascular Medicine 656
- Internal Medicine 91
- Endocrinology, Diabetes and Metabolism 288
- Nephrology 84
- Infectious Diseases 187
Countries citing papers authored by Jianyong Ma
This map shows the geographic impact of Jianyong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianyong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianyong Ma more than expected).
Fields of papers citing papers by Jianyong Ma
This network shows the impact of papers produced by Jianyong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianyong Ma. The network helps show where Jianyong Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianyong Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2023 | 18 | |
| 3 | 2023 | 14 | |
| 4 | 2023 | 14 | |
| 5 | 2023 | 45 | |
| 6 | 2023 | 19 | |
| 7 | 2023 | 39 | |
| 8 | 2022 | 14 | |
| 9 | 2022 | 13 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 2 | |
| 12 | 2021 | 0 | |
| 13 | 2021 | 60 | |
| 14 | 2021 | 21 | |
| 15 | 2021 | 13 | |
| 16 | 2021 | 29 | |
| 17 | 2020 | 27 | |
| 18 | 2020 | 51 | |
| 19 | 2020 | 14 | |
| 20 | 2017 | 48 |
About Jianyong Ma
Jianyong Ma is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Nephrology, having authored 86 papers that have together received 1.8k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (27 papers), Cardiovascular Function and Risk Factors (14 papers), COVID-19 Clinical Research Studies (9 papers), Venous Thromboembolism Diagnosis and Management (9 papers), Cardiac Arrhythmias and Treatments (8 papers), Effects and risks of endocrine disrupting chemicals (7 papers), Heart Failure Treatment and Management (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (656 citations), Internal Medicine (91 citations) and Endocrinology, Diabetes and Metabolism (288 citations). Jianyong Ma has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Wengen Zhu, Peng Yu, Xiao Liu, Menglu Liu, Xiao Liu, Ziqi Tan, Hongsheng Wang, Huilei Zhao, Yue Zhou and Yujie Zhao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.